NASDAQ

Aclaris Therapeutics, Inc. (ACRS)

♥ 688 Thanks from members

Live price chart, market sentiment, and community perspectives for Aclaris Therapeutics, Inc. (NASDAQ: ACRS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Aclaris Therapeutics TeamLeadership: Neal Walker (Chairman and CEO)Holder: Perceptive AdvisorsHolder: Bain Capital Life SciencesHolder: BlackRock, Inc.ATI-450Kilo-moleculesKinase inhibitors#ACRS stock#Aclaris Therapeutics#immuno inflammatory drugs#kinase inhibitors#biotech pipeline